Autologous Stem Cell Transplantation for Chronic Lymphocytic Leukemia - Still a Valid Treatment Option, or is the Game Over?

Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab (FCR) has been established as the current standard of care for young and fit patients with chronic lymphocytic leukemia (CLL). In the early nineties of the last century, long before the advent of fludarabine or antibody-based strat...

Descripción completa

Detalles Bibliográficos
Autores principales: McClanahan, Fabienne, Dreger, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2012
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507531/
https://www.ncbi.nlm.nih.gov/pubmed/23205259
http://dx.doi.org/10.4084/MJHID.2012.071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507531/
https://www.ncbi.nlm.nih.gov/pubmed/23205259
http://dx.doi.org/10.4084/MJHID.2012.071

Ejemplares similares